Pricing Log in Create free account
Saturday 17 October 2026 Export PCRX’s income statement to Excel — free account

Pacira BioSciences, Inc.

PCRX Healthcare Drug Manufacturers Specialty & Generic

Pacira BioSciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $726.4 million, up 3.63% from fiscal 2024. In the quarter to June 2026, revenue grew 6.24%, EPS grew 209.1%, free cash flow grew 502.5% and total debt fell 37.4%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.

36.35 0.02 +0.06%
Market cap
$1.5B
P/E
104×
Fwd P/E
33.7×
Dividend yield
—
F-score
8/9
Altman Z
2.02
Beneish M
−2.93
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Pacira BioSciences, Inc. (PCRX) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, Pacira BioSciences, Inc. (PCRX) trades at a P/E ratio of 104×. Over the past ten years it has ranged from 0.0× (September 2025) to 1,910× (December 2015); the current reading is higher than 77% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 19.2× and above the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 173× —
FY2024 0.0× —
FY2023 35.6× (67.53%)
FY2022 109× 72.88%
FY2021 63.3× 257.75%
FY2020 17.7× —
FY2019 0.0× —
FY2018 0.0× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly newest first

Period P/E ratio Change
Jun 2026 72.5× (61.51%)
Mar 2026 188× 9.16%
Dec 2025 173× 207.98%
Sep 2025 56.0× —
42 more quarters

Against its own ten years

Low 0.0× High 1,910×
Ten-year median 13.7×
Current reading's percentile 61

P/E ratio against peers

Company P/E ratio
XERS Xeris Biopharma Holdings, Inc. compare n/m
HROW Harrow, Inc. compare n/m
BCRX BioCryst Pharmaceuticals, Inc. compare n/m
AMPH Amphastar Pharmaceuticals, Inc. compare 14.9×
ANIP ANI Pharmaceuticals, Inc. compare 14.9×
PAHC Phibro Animal Health Corporation compare 15.8×
CRON Cronos Group Inc. compare 16.1×
PCRX Pacira BioSciences, Inc. 104×
ETON Eton Pharmaceuticals, Inc. compare 107×
Drug Manufacturers Specialty & Generic industry median 19.2×
Healthcare sector median 23.0×
Market median 18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on PCRX